Mural Oncology plc (NASDAQ: MURA)
$3.45
+0.1400 ( +4.23% ) 289.3K
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
Market Data
Open
$3.45
Previous close
$3.31
Volume
289.3K
Market cap
$58.39M
Day range
$3.28 - $3.57
52 week range
$2.88 - $17.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Nov 15, 2023 |
3 | Insider transactions | 2 | Nov 15, 2023 |
3 | Insider transactions | 2 | Nov 15, 2023 |
3 | Insider transactions | 2 | Nov 07, 2023 |
3 | Insider transactions | 2 | Nov 07, 2023 |
3 | Insider transactions | 2 | Nov 07, 2023 |
3 | Insider transactions | 2 | Nov 07, 2023 |
3 | Insider transactions | 2 | Nov 07, 2023 |
3 | Insider transactions | 1 | Nov 07, 2023 |
8-k | 8K-related | 1 | Oct 31, 2023 |